Richard Burr: “So, in other words, the medical alerts that went out were ignored or devalued from a standpoint of importance?”

Without Orrin, we wouldn't have a generic drug industry.

What does it mean for a small company when FDA misses these goals, and what does it mean to patients?

I always like to bring things back to the present because I have a tremendous amount of respect for all four of you.

He was also the author of the Americans With Disabilities Act, helping improve the lives of millions of Americans with disabilities.